Thursday, October 29, 2026

Hyundai Bioscience’s Xafty Clears Genotoxicity Study, Supporting U.S. Phase 2 Respiratory Virus Trial Plans

Hyundai Bioscience's Xafty shows no genotoxicity in tests, aiding its Phase 2 trial plans for respiratory viral infections.

How COLO eDX is Changing Colon Cancer Monitoring: Key Insights from iCRS 2026

Gencurix confirms its blood-based colon cancer test can detect cancer and monitor recurrence post-surgery.

THE SPY EPIDEMIC: We Are Under Attack! North Korea’s Agent Network Is Deep Inside South Korea

A North Korean defector received a suspended sentence for sharing military intelligence about a radar base in Jeju with North Korea.

Tae Hwan Kim

No posts to display

Top News

- Our Sponsors Ad -

Follow us